Clinical and experimental study on the induction of operational tolerance through the combined use of hematopoietic progenitor cell transplantation and solid organ transplantation.
To prevent graft rejection, lifelong pharmacological immunosuppression remains the standard ofcare. While these drugs are effective in reducing the risk of acute rejection, their chronic usepresents significant challenges